0 Comments
0 Shares
97 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Cardiac Biomarker Testing Market: Rapid Diagnostics, Growth Opportunities & Industry AnalysisAccording to the latest report published by Data Bridge Market Research, the Cardiac Markers Rapid Tests and Point of Care (POC) Market CAGR Value Data Bridge Market Research analyses that the global cardiac markers rapid tests and point of care (POC) market which was USD 137.46 million in 2022, is expected to reach USD 1303 million by 2030, and is expected to undergo a CAGR...0 Comments 0 Shares 385 Views 0 Reviews
-
EPO Biomarker Testing Market Expands as Demand for Early Disease Detection and Personalized Treatment RisesThe global healthcare industry is witnessing significant advancements in biomarker-based diagnostics as researchers and clinicians increasingly focus on precision medicine, early disease detection, and improved treatment monitoring. Among these innovations, the Erythropoietin (EPO) Biomarkers Market is gaining momentum due to the growing importance of erythropoietin-related biomarkers in...0 Comments 0 Shares 598 Views 0 Reviews
-
Non-Small Cell Lung Cancer Market: Impact of Molecular Testing and Biomarker-Based TherapiesValued at USD 38.88 billion in 2025, the non-small cell lung cancer market is projected to reach USD 42.64 billion in 2026 and USD 129.88 billion by 2034, growing at a CAGR of 14.3% during the forecast period 2026–2034. Expansion is propelled by a fast-changing treatment landscape in which targeted therapy and immunotherapy are improving survival outcomes in advanced and metastatic...0 Comments 0 Shares 95 Views 0 Reviews
-
Prostate Cancer Biomarker Market Growth: The Rising Role of Genomic Testing in Personalized CarePolaris Market Research releases its new research report on the Prostate Cancer Biomarker market, which provides comprehensive insight into the current market landscape and future outlook. It discusses all the major forces that can help drive growth in the market. This report studies the effect of rising demand, technology, applications, investments, and competition. It offers a comprehensive...0 Comments 0 Shares 569 Views 0 Reviews
-
Why Biomarker Testing Is Essential in AMLAcute myeloid leukemia is an aggressive cancer of the blood and bone marrow that requires prompt diagnosis and treatment. In recent years, biomarker testing has become essential to AML care, providing information about the genetic and molecular characteristics of the disease. This information helps clinicians classify AML, determine prognosis, and select the most appropriate therapies. Without...0 Comments 0 Shares 280 Views 0 Reviews
-
Why Biomarker Testing Is Essential in AMLAcute myeloid leukemia is an aggressive cancer of the blood and bone marrow that requires prompt diagnosis and treatment. In recent years, biomarker testing has become essential to AML care, providing information about the genetic and molecular characteristics of the disease. This information helps clinicians classify AML, determine prognosis, and select the most appropriate therapies. Without...0 Comments 0 Shares 193 Views 0 Reviews
-
Why Biomarker Testing Matters in AMLAcute myeloid leukemia is an aggressive cancer of the blood and bone marrow that requires prompt diagnosis and treatment. In recent years, biomarker testing has become essential to AML care, providing information about the genetic and molecular characteristics of the disease. This information helps clinicians classify AML, determine prognosis, and select the most appropriate therapies. Without...0 Comments 0 Shares 333 Views 0 Reviews
-
Companion Diagnostics Market Growth Through Biomarker-Guided TreatmentThe companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...0 Comments 0 Shares 1K Views 0 Reviews
-
Creatine Kinase Reagent Market Revenue Forecast and Strategic AnalysisThe global healthcare diagnostics industry continues to witness significant advancements in laboratory testing technologies, driving demand for specialized reagents used in clinical diagnostics. Creatine kinase reagents play a critical role in measuring creatine kinase enzyme activity in blood samples, helping healthcare professionals diagnose and monitor conditions such as myocardial...0 Comments 0 Shares 2K Views 0 Reviews
-
Pancreatic Cancer Diagnostic Market Growth Driven by Advanced Testing TechnologiesThe pancreatic cancer diagnostic market is entering a period of technological transformation as healthcare providers seek more reliable ways to identify one of the deadliest forms of cancer. With many patients diagnosed only after the disease has advanced, the need for earlier detection, improved diagnostic accuracy, and accessible testing solutions is becoming increasingly important. The...0 Comments 0 Shares 679 Views 0 Reviews
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek